Nanohale AG (ETR:FYB)

BRIEF

published on 06/18/2025 at 16:48, 7 months 11 days ago

Formycon AG's AGM Approves New Resolutions

Supervisory Board Formycon AG Biosimilars Financial Outlook AGM Resolutions
PRESS RELEASE

published on 06/18/2025 at 16:43, 7 months 11 days ago

Ordinary Annual General Meeting of Formycon AG approves all proposed resolutions by large majorities
Formycon AG's Ordinary Annual General Meeting approval of resolutions and expansion of Supervisory Board demonstrated strong shareholder support and strategic growth focus

Annual General Meeting Supervisory Board Formycon AG Biosimilars Resolutions
BRIEF

published on 06/18/2025 at 06:30, 7 months 12 days ago

Formycon AG Launches Subscription for New Corporate Bond

Capital Markets Interest Rates Formycon AG Corporate Bond Biosimilar Development
PRESS RELEASE

published on 06/18/2025 at 06:25, 7 months 12 days ago

Formycon AG: Subscription period for 2025/2029 corporate bond has started
Formycon AG announces the start of the subscription period for the 2025/2029 corporate bond with a target volume of EUR 50 million, featuring a variable interest rate. Investors can submit subscription offers until June 27, 2025

Growth Strategy Formycon AG Interest Rate Corporate Bond Subscription Period
BRIEF

published on 06/17/2025 at 08:06, 7 months 13 days ago

Formycon Announces EUR 50 Million Corporate Bond Issuance for Growth

Growth Strategy Corporate Bond Formycon EUR 50 Million Biosimilar Market
PRESS RELEASE

published on 06/17/2025 at 08:01, 7 months 13 days ago

Formycon plans public corporate bond issuance to support next growth phase within attractive Biosimilar markets
Formycon AG plans EUR 50 million corporate bond issuance to support growth in Biosimilar markets. Bond led by IKB Deutsche Industriebank AG & Pareto Securities AS

Formycon AG Growth Corporate Bond IKB Deutsche Industriebank Biosimilar Markets
BRIEF

published on 06/17/2025 at 08:00, 7 months 13 days ago

Formycon to Launch €50 Million Bond for Growth

Growth Strategy Formycon AG Bond Issuance €50 Million Biosimilar Products
PRESS RELEASE

published on 06/17/2025 at 07:55, 7 months 13 days ago

EQS-Adhoc: Formycon plans to issue a public senior unsecured floating rate bond with target volume of EUR 50 million to support further company growth
Formycon AG plans EUR 50 million senior unsecured bond issuance for company growth. Joint Lead Managers: IKB Deutsche Industriebank AG, Pareto Securities AS

Formycon AG Bond Issuance EUR 50 Million Senior Unsecured Joint Lead Managers
BRIEF

published on 06/05/2025 at 06:35, 7 months 25 days ago

Lucentis® Biosimilar FYB201/Ranivisio® Gains Approval in Brazil

Formycon AG Retinal Diseases Lucentis® Biosimilar Brazil Approval Biomm Partnership
PRESS RELEASE

published on 06/05/2025 at 06:30, 7 months 25 days ago

Lucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil
Brazil approves Formycon AG's Lucentis biosimilar FYB201/Ranivisio, marking the beginning of Latin America rollout. Commercial partnership with Biomm established

Formycon AG Lucentis Biosimilar Brazil Approval Biomm Partnership Market Rollout

Published on 01/30/2026 at 14:00, 1 hour 57 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 22 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 7 hours 57 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 13 hours 42 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 15 hours 57 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 15:33, 23 minutes ago

Original-Research: Aroundtown SA (von First Berlin Equity Research GmbH): Kaufen
Published on 01/30/2026 at 15:29, 27 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding Fitch Ratings
Published on 01/30/2026 at 14:52, 1 hour 4 minutes ago

Edison issues report on Henderson Far East Income (HFEL)
Published on 01/30/2026 at 14:11, 1 hour 45 minutes ago

SBF AG expects stable to positive business development in a challenging environment for 2026
Published on 01/30/2026 at 13:30, 2 hours 26 minutes ago

North Peak Expands Wabash Gold Mineralization at Prospect Mountain, Nevada

View all EQS

Published on 01/30/2026 at 08:00, 7 hours 57 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 21 hours 57 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 12 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 12 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 22 hours 17 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News